Alliance Defending Freedom, the legal aid organization that litigated Dobbs v. Jackson, is now taking its anti-abortion fight to the U.S. Food and Drug Administration, seeking an injunction to end the use of the abortion pill mifepristone.

Alliance Defending Freedom—in a 113-page complaint that addresses the 22-year history of FDA oversight of the drug—alleges mifepristone was improperly granted accelerated approval as a drug for “treating serious or life-threatening illnesses.”

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]